Several factors must be considered in support of extended monitoring: clinical conditions, such as renal failure, vitamin D deficiency, diabetes, and obesity, may require a prolongation of monitoring with an increase in the number of samples, either by modifying the kinetics of PTH or for other causes29–32. Here, PTH is linked to obesity due to melanocortin 4 receptor deficiency.